Literature DB >> 18563324

Hemodynamic changes on color Doppler flow imaging and intravenous contrast-enhanced ultrasound for assessing transplanted liver and early diagnosis of complications.

Daozhong Huang1, Yunchao Chen, Kaiyan Li, Qingping Zhang.   

Abstract

The value of color Doppler flow imaging (CDFI) and intravenous contrast-enhanced ultrasound (CEUS) for assessing the transplanted liver and early diagnosing complications by examining hemodynamic changes was discussed. Seventy-five patients with orthotopic liver transplantation (OLT) underwent CDFI. The following parameters were measured: peak systolic velocity (PS), resistance index (RI) and Doppler perfusion index (DPI) of the hepatic artery (HA), time average velocity (TAV) of portal vein (PV) and velocity of hepatic vein (HV) in different stages postoperation. And 11 patients of them received CEUS. Thirty healthy subjects were enrolled as controls. The results showed that: (1) In 23 patients without obvious complications, TAV of PV within 15 days post-operation was significantly higher than in controls (P<0.05), PS and DPI of HA within 7 days postoperation were lower, but RI was higher than in controls (P<0.05); (2) When the hepatic artery thrombosis (HAT) occurred, PS and DPI of HA were obviously decreased, but TAV of PV significantly increased like a high saw-tooth wave; (3) While rejection occurred, both TAV of PV and PS of HA were decreased with the increase in RI of HA, and the triphasic wave of HV disappeared and displayed as saw-tooth wave; (4) The incidence of biliary complications in liver transplantation was increased when DPI was reduced; (5) Seven cases of hepatic carcinoma relapse after OLT demonstrated hyperecho in the arterial phase and hypoecho in the portal and later phase on CEUS; (6) In 2 cases of HA thrombus, there was no visualized enhancement in arterial phase of CEUS, but enhancement during the portal vein and parenchymal phase. It was concluded that the hemodynamic changes of PV, HA and HV in the transplanted liver are valuable for assessing the transplanted liver and early diagnosing complications on CDFI and CEUS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563324     DOI: 10.1007/s11596-008-0312-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

Review 1.  Vascular complications related to liver transplantation.

Authors:  J Pawlak; T Wróblewski; P Małkowski; P Nyckowski; K Zieniewicz; I Grzelak; A Alsharabi; B Michałowicz; M Krawczyk; A Karwowski
Journal:  Transplant Proc       Date:  2000-09       Impact factor: 1.066

2.  Contrast-enhanced ultrasound improves hepatic vessel visualization after orthotopic liver transplantation.

Authors:  C Herold; T Reck; R Ott; H T Schneider; D Becker; D Schuppan; E G Hahn
Journal:  Abdom Imaging       Date:  2001 Nov-Dec

3.  Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study.

Authors:  F Piscaglia; G Zironi; S Gaiani; A Mazziotti; A Cavallari; L Gramantieri; M Valgimigli; L Bolondi
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

Review 4.  The role of hepatic arterial Doppler ultrasound after liver transplantation: an 'audit cycle' evaluation.

Authors:  P M Maceneaney; D E Malone; S J Skehan; M P Curry; J C Miller; R G Gibney; O Traynor; P A Mccormick
Journal:  Clin Radiol       Date:  2000-07       Impact factor: 2.350

5.  The role of hepatic vein Doppler in diagnosing acute rejection following paediatric liver transplantation.

Authors:  P D Britton; D J Lomas; R A Coulden; P Farman; S Revell
Journal:  Clin Radiol       Date:  1992-04       Impact factor: 2.350

6.  Vascular complications after orthotopic liver transplantation.

Authors:  A N Langnas; W Marujo; R J Stratta; R P Wood; B W Shaw
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

  6 in total
  1 in total

Review 1.  Application of contrast-enhanced ultrasound after liver transplantation: Current status and perspectives.

Authors:  Jie Ren; Tao Wu; Bo-Wen Zheng; Ying-Yi Tan; Rong-Qin Zheng; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.